This medication inhibits the function of leukocytes and tissue macrophages. Prezolon restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Prezolon contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in inflammation. This medicine decreases capillary permeability caused by histamine release. Prezolon inhibits the activity of fibroblasts and collagen formation.